Stock 300813 ZHEJIANG TAILIN BIOENGINEERING CO.,LTD
Add to a list
To use this feature you must be a member
Log inSign up

Financials Zhejiang Tailin BioEngineering Co.,Ltd

Equities

300813

CNE100003S89

Advanced Medical Equipment & Technology

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 13/05/2024 BST 		5-day change 1st Jan Change
23.94 CNY -12.95% Intraday chart for Zhejiang Tailin BioEngineering Co.,Ltd +28.43% -2.37%
04-24 Zhejiang Tailin BioEngineering Co.,Ltd Proposes Final Cash Dividend for 2023 CI
04-23 Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Valuation

Fiscal Period: December 2020 2021 2022 2023
Capitalization 1 2,553 5,197 3,863 2,665
Enterprise Value (EV) 1 2,231 4,882 3,432 2,425
P/E ratio 51.7 x 82 x 50.5 x 144 x
Yield 0.41% 0.3% 0.65% 0.41%
Capitalization / Revenue 12.7 x 18.3 x 10.3 x 9.87 x
EV / Revenue 11.1 x 17.2 x 9.18 x 8.99 x
EV / EBITDA 49.3 x 73.6 x 46.6 x 177 x
EV / FCF 28.9 x -391 x 143 x -13.1 x
FCF Yield 3.47% -0.26% 0.7% -7.64%
Price to Book 5.75 x 10.4 x 5.97 x 4.11 x
Nbr of stocks (in thousands) 108,098 108,098 108,103 108,679
Reference price 2 23.62 48.08 35.74 24.52
Announcement Date 25/04/21 18/04/22 03/04/23 23/04/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 159.1 180.9 200.2 283.2 373.9 269.9
EBITDA 1 55.89 40.56 45.23 66.34 73.64 13.68
EBIT 1 53.13 33 36.94 59.8 64.82 2.766
Operating Margin 33.39% 18.24% 18.45% 21.11% 17.34% 1.03%
Earnings before Tax (EBT) 1 53.7 38.52 51.73 69.64 79.95 21.98
Net income 1 48.21 34.41 48.39 63.53 79.69 19.67
Net margin 30.31% 19.02% 24.16% 22.43% 21.31% 7.29%
EPS 2 0.5948 0.4231 0.4567 0.5865 0.7077 0.1700
Free Cash Flow 1 -4.564 -17.33 77.32 -12.48 23.95 -185.2
FCF margin -2.87% -9.58% 38.61% -4.41% 6.41% -68.65%
FCF Conversion (EBITDA) - - 170.95% - 32.52% -
FCF Conversion (Net income) - - 159.79% - 30.05% -
Dividend per Share - 0.2885 0.0962 0.1442 0.2308 0.1000
Announcement Date 30/12/19 27/04/20 25/04/21 18/04/22 03/04/23 23/04/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 44.4 51.9 322 315 432 239
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -4.56 -17.3 77.3 -12.5 23.9 -185
ROE (net income / shareholders' equity) 28.3% 16.2% 14.4% 13.5% 13.9% 2.84%
ROA (Net income/ Total Assets) 14.8% 7.9% 5.72% 6.25% 5.13% 0.18%
Assets 1 325.8 435.5 845.5 1,016 1,552 10,789
Book Value Per Share 2 2.400 2.830 4.110 4.600 5.990 5.970
Cash Flow per Share 2 0.5500 0.6400 2.980 2.800 5.340 3.650
Capex 1 42.3 22.4 7.07 25.9 29.1 176
Capex / Sales 26.58% 12.36% 3.53% 9.15% 7.79% 65.31%
Announcement Date 30/12/19 27/04/20 25/04/21 18/04/22 03/04/23 23/04/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
ZHEJIANG TAILIN BIOENGINEERING CO.,LTD Stock Zhejiang Tailin BioEngineering Co.,Ltd
-2.37% 413M
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+12.06% 225B
DANAHER CORPORATION Stock Danaher Corporation
+12.07% 186B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+13.88% 135B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+27.12% 107B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+0.91% 63.56B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+6.74% 51.32B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+13.39% 51.04B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
+8.81% 43.3B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+4.14% 36.99B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. 300813 Stock
  4. Financials Zhejiang Tailin BioEngineering Co.,Ltd